80 related articles for article (PubMed ID: 23481458)
21. Achieving optimal lipid goals in patients with coronary artery disease.
Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
[TBL] [Abstract][Full Text] [Related]
22. Model-based simulation to explore the cost-effectiveness of following practice guidelines for triglyceride and low-density lipoprotein cholesterol control among patients with diabetes mellitus and mixed dyslipidemia.
Sorensen SV; Frick KD; Wade A; Simko R; Burge R
Clin Ther; 2009 Apr; 31(4):862-79. PubMed ID: 19446159
[TBL] [Abstract][Full Text] [Related]
23. Hypertriglyceridemia: a review of clinical relevance and treatment options: focus on cerivastatin.
Breuer HW
Curr Med Res Opin; 2001; 17(1):60-73. PubMed ID: 11464448
[TBL] [Abstract][Full Text] [Related]
24. Opportunity for intervention to achieve American Heart Association guidelines for optimal lipid levels in high-risk women in a managed care setting.
Mosca L; Merz NB; Blumenthal RS; Cziraky MJ; Fabunmi RP; Sarawate C; Watson KE; Willey VJ; Stanek EJ
Circulation; 2005 Feb; 111(4):488-93. PubMed ID: 15687138
[TBL] [Abstract][Full Text] [Related]
25. Hypertriglyceridemia and residual dyslipidemia in statin-treated, patients with diabetes at the highest risk for cardiovascular disease and achieving very-low low-density lipoprotein-cholesterol levels.
Querton L; Buysschaert M; Hermans MP
J Clin Lipidol; 2012; 6(5):434-42. PubMed ID: 23009779
[TBL] [Abstract][Full Text] [Related]
26. Serum lipid profiles and their relationship to cardiovascular disease in the elderly: the PREV-ICTUS study.
Lozano JV; Pallarés V; Cea-Calvo L; Llisterri JL; Fernández-Pérez C; Martí-Canales JC; Aznar J; Gil-Guillén V; Redón J;
Curr Med Res Opin; 2008 Mar; 24(3):659-70. PubMed ID: 18218194
[TBL] [Abstract][Full Text] [Related]
27. Lipid-lowering treatment in hypercholesterolemic patients: the CEPHEUS Thailand survey.
Sukonthasarn A; Homsanit M; Prommete B; Chotinaiwattarakul C; Piamsomboon C; Likittanasombat K
J Med Assoc Thai; 2011 Dec; 94(12):1424-34. PubMed ID: 22295727
[TBL] [Abstract][Full Text] [Related]
28. Lipid therapy utilization rates in a managed-care mixed dyslipidemia population.
Toth PP; Zarotsky V; Sullivan JM; Laitinen D
J Clin Lipidol; 2008 Oct; 2(5):365-74. PubMed ID: 21291762
[TBL] [Abstract][Full Text] [Related]
29. Impact of optimal lipid value achievement between 2005 and 2009 in patients with mixed dyslipidaemia on cardiovascular event rates.
Cziraky MJ; Tan H; Bullano MF; Yu J; Schiebinger R; Willey VJ
Int J Clin Pract; 2011 Apr; 65(4):425-35. PubMed ID: 21401832
[TBL] [Abstract][Full Text] [Related]
30. Lipid-modifying therapy and attainment of cholesterol goals in Europe: the Return on Expenditure Achieved for Lipid Therapy (REALITY) study.
Van Ganse E; Laforest L; Alemao E; Davies G; Gutkin S; Yin D
Curr Med Res Opin; 2005 Sep; 21(9):1389-99. PubMed ID: 16197657
[TBL] [Abstract][Full Text] [Related]
31. Comparison of fluvastatin + fenofibrate combination therapy and fluvastatin monotherapy in the treatment of combined hyperlipidemia, type 2 diabetes mellitus, and coronary heart disease: a 12-month, randomized, double-blind, controlled trial.
Derosa G; Cicero AE; Bertone G; Piccinni MN; Ciccarelli L; Roggeri DE
Clin Ther; 2004 Oct; 26(10):1599-607. PubMed ID: 15598476
[TBL] [Abstract][Full Text] [Related]
32. Cardiovascular risk factors and recommended lipid goals attainment among patients referred in a tertiary care lipid clinic.
Pirro M; Del Giorno R; Lupattelli G; Mannarino MR; Roscini AR; Covelli D; Schillaci G; Pasqualini L; Bagaglia F; Siepi D; Mannarino E
Eur J Intern Med; 2011 Aug; 22(4):412-7. PubMed ID: 21767761
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA).
Pettersson B; Ambegaonkar B; Sazonov V; Martinell M; Stålhammar J; Wändell P
BMC Public Health; 2010 Nov; 10():737. PubMed ID: 21114824
[TBL] [Abstract][Full Text] [Related]
34. Raising high-density lipoprotein cholesterol with reduction of cardiovascular risk: the role of nicotinic acid--a position paper developed by the European Consensus Panel on HDL-C.
Chapman MJ; Assmann G; Fruchart JC; Shepherd J; Sirtori C;
Curr Med Res Opin; 2004 Aug; 20(8):1253-68. PubMed ID: 15324528
[TBL] [Abstract][Full Text] [Related]
35. Distribution of lipid phenotypes in community-living men with coronary heart disease. High prevalence of isolated low levels of high-density lipoprotein cholesterol.
Rubins HB; Schectman G; Wilt TJ; Iwane MK
Arch Intern Med; 1992 Dec; 152(12):2412-6. PubMed ID: 1456850
[TBL] [Abstract][Full Text] [Related]
36. Achieving lipoprotein goals in patients at high risk with severe hypercholesterolemia: efficacy and safety of ezetimibe co-administered with atorvastatin.
Stein E; Stender S; Mata P; Sager P; Ponsonnet D; Melani L; Lipka L; Suresh R; Maccubbin D; Veltri E;
Am Heart J; 2004 Sep; 148(3):447-55. PubMed ID: 15389231
[TBL] [Abstract][Full Text] [Related]
37. Serum lipids and their relationship with other coronary risk factors in healthy subjects in a city clinic.
Khoo KL; Tan H; Liew YM
Med J Malaysia; 1997 Mar; 52(1):38-52. PubMed ID: 10968052
[TBL] [Abstract][Full Text] [Related]
38. Twelve-week, multicenter, randomized, open-label comparison of the effects of rosuvastatin 10 mg/d and atorvastatin 10 mg/d in high-risk adults: a DISCOVERY study.
Strandberg TE; Feely J; Sigurdsson EL;
Clin Ther; 2004 Nov; 26(11):1821-33. PubMed ID: 15639694
[TBL] [Abstract][Full Text] [Related]
39. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
[TBL] [Abstract][Full Text] [Related]
40. Contemporary management of dyslipidemia in high-risk patients: targets still not met.
Yan AT; Yan RT; Tan M; Hackam DG; Leblanc KL; Kertland H; Tsang JL; Jaffer S; Kates ML; Leiter LA; Fitchett DH; Langer A; Goodman SG;
Am J Med; 2006 Aug; 119(8):676-83. PubMed ID: 16887414
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
